Chemotherapy Toxicity Considerations in Soft Tissue Sarcoma
0 意见
• 07/18/23
0
0
嵌入
The panelists, Brian Van Tine, MD, PhD; Robin Jones, MD, MRCP; Andrew Wagner, MD, PhD; Lor Randall, MD, FACS; Shreyaskumar Patel, MD; and Jonathan Trent, MD, PhD; discuss the factors they consider when balancing the risks and benefits of chemotherapy treatment in soft tissue sarcoma.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论